Free iron, total F2‐isoprostanes and total F4‐neuroprostanes in a model of neonatal hypoxic–ischemic encephalopathy: neuroprotective effect of melatonin
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Oxidative stress due to free radical formation and initiation of abnormal oxidative reactions is involved in several diseases of newborns, such as hypoxic–ischemic encephalopathy. Melatonin, an endogenously produced indoleamine primarily formed in the pineal gland, is a potent free radical scavenger as well as an indirect antioxidant. The present study was conducted to evaluate the formation of oxidative damage mediators and the possible effect of melatonin treatment in a model of hypoxic–ischemic encephalopathy in 7‐day‐old rats. Pups were subjected to permanent ligation of the right common carotid artery and exposed for 2.5 hr to a nitrogen–oxygen mixture (92% and 8%, respectively) (hypoxia–ischemia, HI). Melatonin was injected intraperitoneally to a group of rats at the dose of 15 mg/kg 30 min before starting the ischemic procedure (HI–Melatonin). After 24 hr of treatment, in homogenized cerebral cortex, desferoxamine (DFO)‐chelatable free iron, total F 2‐isoprostanes and total F 4‐neuroprostanes, originating from the free radical‐catalyzed peroxidation of arachidonic and docosahexaenoic acids, respectively, were determined. HI induced a significant increase in DFO‐chelatable iron, total F 2‐isoprostanes and F 4‐neuroprostanes in both right and left side of the cerebral cortex. In HI–Melatonin‐treated animals the levels of free iron, F 2‐isoprostanes, and F 4‐neuroprostanes were significantly lower than that in HI rats and the values were similar to controls. These data show the important neuroprotective role of melatonin in reducing oxidative damage resulting from HI. Melatonin could represent a potential safe approach to perinatal brain damage in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tan, D., Manchester, L. C., Terron, M. P., Flores, L. J., & Reiter, R. J. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00407.x · Cited by 1,601 · cited 2×
“It has, as well as several of its metabolites, the ability to remove singlet oxygen (1O2), superoxide anion radical (O•)2), hydroperoxide (H2O2), •OH and lipid peroxide radical (LOO•) [28, 29].”
BackgroundFatty acid composition of brain phospholipids in aging and in Alzheimer’s disease
Söderberg, M., Edlund, C., Kristensson, K., & Dallner, G. (1991) · Lipids · doi:10.1007/bf02536067 · Cited by 667 · cited 1×
“F4-isoprostanes, another class of prostanoids (named F4-neuroprostanes, F4-NeuroPs), originate from the free radical catalyzed peroxidation of docosahexaenoic acid (DHA; C22:6x3), an essential constituent of nervous tissue, mainly present esterified to phospholipids in the brain, [23] and highly susceptible to oxidati…”
BackgroundF4 ‐ Isoprostanes as Specific Marker of Docosahexaenoic Acid Peroxidation in Alzheimer's Disease
Nourooz‐Zadeh, J., Liu, E. H. C., Yhlen, B., Änggåard, E. E., & Halliwell, B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720734.x · Cited by 187
The role of iron neurotoxicity in ischemic stroke
Selim, M. H., & Ratan, R. R. (2004) · Ageing Research Reviews · doi:10.1016/j.arr.2004.04.001 · Cited by 158 · cited 2×
“Nitric oxide metabolites are also thought to release iron from ferritin after stroke [13].”
BackgroundInfluential
Cited by
García, J. J., López‐Pingarrón, L., Almeida‐Souza, P., Tres, A., Escudero, P., García‐Gil, F. A., Tan, D., Reiter, R. J., Ramírez, J. M., & Bernal‐Pérez, M. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12128 · Cited by 476
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“Melatonin can be protective (Sharma and Haldar 2009).”
BackgroundInfluentialNeurotoxins: Free radical mechanisms and melatonin protection
J. Reiter, R., C. Manchester, L., & Tan, D.-X. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246236 · Cited by 179
Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome
De Felice, C., Della Ragione, F., Signorini, C., Leoncini, S., Pecorelli, A., Ciccoli, L., Scalabrì, F., Marracino, F., Madonna, M., Belmonte, G., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.006 · Cited by 126
Self-citationRedox imbalance and morphological changes in skin fibroblasts in typical Rett syndrome
Signorini, C., Leoncini, S., De Felice, C., Pecorelli, A., Meloni, I., Ariani, F., Mari, F., Amabile, S., Paccagnini, E., Gentile, M., et al. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/195935 · Cited by 61
“Measured ions were the product ions at m/z 299 and m/z 303 derived from the [M−181] precursor ions (m/z 569 and m/z 573) produced from 15-F 2t-IsoPs and the tetradeuterated derivative of prostaglandin F 2α (PGF 2α -d 4 ), respectively [29, 30].”
MethodInfluentialSelf-citation
Metadata
- Authors
- Signorini, C., Ciccoli, L., Leoncini, S., Carloni, S., Perrone, S., Comporti, M., Balduini, W., & Buonocore, G.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2009-01-29
- Volume
- 46
- Issue
- 2
- Pages
- 148-154
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W2068007862
- Cited by
- 73
- References
- 4
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Free iron, total F2‐isoprostanes and total F4‐neuroprostanes in a model of neonatal hypoxic–ischemic encephalopathy: neuroprotective effect of melatonin. https://app.cochat.ai/papers/10.1111/j.1600-079x.2008.00639.x
- The paper
- Signorini, C., Ciccoli, L., Leoncini, S., Carloni, S., Perrone, S., Comporti, M., Balduini, W., & Buonocore, G. (2009). Free iron, total F2‐isoprostanes and total F4‐neuroprostanes in a model of neonatal hypoxic–ischemic encephalopathy: neuroprotective effect of melatonin. Journal of Pineal Research. https://doi.org/10.1111/j.1600-079x.2008.00639.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.